SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-24-020011
Filing Date
2024-05-02
Accepted
2024-05-02 16:11:10
Documents
75
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q abt-20240331.htm   iXBRL 10-Q 986367
2 EX-31.1 q1202410qex311.htm EX-31.1 9490
3 EX-31.2 q1202410qex312.htm EX-31.2 9477
4 EX-32.1 q1202410qex321.htm EX-32.1 4985
5 EX-32.2 q1202410qex322.htm EX-32.2 4979
  Complete submission text file 0001628280-24-020011.txt   6370250

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT abt-20240331.xsd EX-101.SCH 43980
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT abt-20240331_cal.xml EX-101.CAL 65327
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT abt-20240331_def.xml EX-101.DEF 262718
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT abt-20240331_lab.xml EX-101.LAB 536227
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT abt-20240331_pre.xml EX-101.PRE 384715
79 EXTRACTED XBRL INSTANCE DOCUMENT abt-20240331_htm.xml XML 996359
Mailing Address 100 ABBOTT PARK ROAD ABBOTT PARK IL 60064-3500
Business Address 100 ABBOTT PARK ROAD ABBOTT PARK IL 60064-3500 2246676100
ABBOTT LABORATORIES (Filer) CIK: 0000001800 (see all company filings)

IRS No.: 360698440 | State of Incorp.: IL | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-02189 | Film No.: 24908340
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)